>HFFEDDFJ_00001 Extracellular matrix-binding protein ebh
MKVVEKELAVVKQQAIESIENAAQQKINDINNHATLTPEQKEAAIAEVNKLKQQAIEQIN
NATDVHSVEEVQQQEQTHIEQFNPEQFTIDQAKSNAIKSITDAIQHMIDEINASKDLTDK
EKQEAISKLNQLKEQAIQAIQRAQSIDEITQQLEQFKAQIKAANPFAKELEKRKKVAISK
IKDISTDAIERIKNSSTGTAEERQAAMNRINEIVLETIRDINNAQTPQQVEAALNNGIAR
ILAVQIVTSNNSKHSSDSDGESNSHISIGYGTVNHPFNSSAIGHKKKLDQDDEIDPLHMR
HFGDRIGNVIKNALGVVGISGLLASFWFFIAKRRRKEDEEEELEIRDNSKDKKKGSIEGT
KHLPLLLAKRRRKEDEEDAIVEEKDSLNNNESLDKVKHTPFFLPKRRRKEDEEDVEVTNE
NTDEKVLQDNEHSPLLIAKRRKDKEVDVETTPSIESNEDDAPLLLAKKKNQKDNQSKGKK
SASKKPSKKLVAKKKKKKSKKNKK
>HFFEDDFJ_00002 14.7 kDa ribonuclease H-like protein
MAKINFDAATKGNPGISTCAVVIKEDDQHYTYTHELGEMDNHTAEWAACIYALKHARELN
VSNALLYTDSKLIADSVNAGYVKNAKFKPYFDQLEIFEQDFDLLFVKWIPREQNKEANQN
AQQALYKLIKKNK
>HFFEDDFJ_00003 queuosine precursor transporter
MYNEILGLVTFIATFVLMVLMYRFFGKQGLIAWVAIGTIIANIQVIKTVEIFGISATLGN
VMFASIYLATDILNDIYGRRVAKRAVWLGFSSTLIMIIVMQLSLHFIPAPEDMAQKALHA
IFDVVPRIALGSIVAYIIGQHIDVFIFSLIKKVFSSDKTFFIRAYGSTFLSSIIDTALFV
AIAFIGSLPGTVVFEIFITTYVLKLASTVFNVPFGYIAKSFYRKGKIDKLDQGY
>HFFEDDFJ_00004 hypothetical protein
MQIISISETPNHNTMKITLSESREGMTSDTYTKVDDSQPAFINDILKVEGVKSIFHVMDF
ISVDKENDANWETVLPKVEAVFE
>HFFEDDFJ_00005 hypothetical protein
MEILRIEPTPSPNTMKVVLSYTREDKLSNTYKKVEENQPRFINQLLSIDGITSIFHVMNF
LAVDKAPKADWEVILPDIKAAFSGESQVLESGKDPQIDKHFGEIKAELLTFKGIPYQIKL
TSADQELREQLPQTYVDHMTQAQTEHDNIVFMRKWLDLGNRYGNIEEVMDGVLEEVLATY
PESQLPVLVKHALEENHAANNYHFYRHVSLDEYHATDNWKTRLRMLNHFPKPTFEDIPLL
DLALSDEKVPVRRQAIVLLGMIESKEILPYLYKGLRDKSPAVRRTAGDCISDLGYPEALP
EMVLLLDDSQKIVRWRAAMFIFDEGNAEQLPALKAHINDNAFEVKLQIEMAISRIENGDE
ALGSVWKQMANRTI
>HFFEDDFJ_00006 hypothetical protein
MNAYDAYMKEIAQQMRGELTQNGFTSLETSEAVLEYMNQVNADDTTFVVINSTCGCAAGL
ARPAAVAVATQNEHRPTNTVTVFAGQDKEATATMREFIQQVPSSPSYALFKGQDLVYFMP
REFIEGRDINDIAMDLKDAFDENCK
>HFFEDDFJ_00007 Thymidylate synthase
MLNSFDAAYHSLCEEVLEIGNTRNDRTNTGTISKFGHQLRFDLSKGFPLLTTKKVSFKLV
ATELLWFIKGDTNIQYLLKYNNNIWNEWAFENYIKSDEYKGPDMTDFGHRALSDPEFNEQ
YKEQMKQFKQRILEDDTFAKQFGDLGNVYGKQWRDWVDKDGNHFDQLKTVIEQIKHNPDS
RRHIVSAWNPTEIDTMALPPCHTMFQFYVQDGKLSCQLYQRSADIFLGVPYNIASYALLT
HLIAKECGLEVGEFVHTFGDAHIYSNHIDAIQTQLARESFNPPTLKINSDKSIFDINYED
LEIVDYESHPAIKAPIAV
>HFFEDDFJ_00008 Dihydrofolate reductase
MTLSILVAHDLQRVIGFENQLPWHLPNDLKHVKKLSTGHTLVMGRKTFESIGKPLPNRRN
VVLTSDTSFNVEGVDVIHSIEDIYQLPGHVFIFGGQTLFEEMIDKVDDMYITVIEGKFRG
DTFFPPYTFEDWEVTSSVEGKLDEKNTIPHTFLHLIRKK
>HFFEDDFJ_00009 DegV domain-containing protein
MTKQIIVTDSTSDLSKEYLEANNIHVIPLSLTIEGVSYVDQVDITSEEFINHIENDEDVK
TSQPAIGEFISAYEELGKDGSEIISIHLSSGLSGTYNTAYQASQMVDANVTVIDSKSISF
GLGYQIQHLVELVKEGVSTSEIVKKLNHLRENIKLFVVIGQLNQLIKGGRISKTKGLIGN
LMKIKPIGTLDDGRLELVHNARTQNSSIQYLKKEIAEFIGDHEIKSVGVTHANVIEYVDK
LKKVFNEAFHVNNYDINVTTPVISAHTGQGAIGLVVLKK
>HFFEDDFJ_00010 Peptide methionine sulfoxide reductase MsrA 2
MTKEYATLAGGCFWCMVKPFTSYPGIKSVVSGYSGGHVDNPTYEQVCTNQTGHVEAVQIT
FDPEVTSFENILDIYFKTFDPTDDQGQFFDRGESYQPVIFYHDEHQKKAAEFKKQQLNEQ
GIFKKPVITPIKPYKNFYPAEDYHQDYYKKNPVHYYQYQRGSGRKAFIESHWGNQNA
>HFFEDDFJ_00011 Peptide methionine sulfoxide reductase MsrB
MLKKDKSELTDIEYIVTQENGTEPPFMNEYWNHFAKGIYVDKISGKPLFTSEEKFHSECG
WPSFSKALDDDEIIELVDKSFGMVRTEVRSEESNSHLGHVFNDGPKESGGLRYCINSAAI
QFIPYEKLEELGYGDLISHFDK
>HFFEDDFJ_00012 PTS system glucose-specific EIIA component
MFKKLFGKGKEVQKDIAIYAPLTGEYVKIEDIPDPVFAQKMMGEGFGINPTEGEVVSPIA
GRVDNVFPTKHAIGLKADNGLELLVHIGLDTVQLDGEGFEVLVSSGDEVNVGDPLVRFNL
EFINNNAKSVISPIIITNTDQAASINIYDENAVIKGETKVIDVTMN
>HFFEDDFJ_00013 hypothetical protein
MKNYSFYQFVMTVRGRHDDKGRLAEEIFDDLAFPKHDDDFNILSDYIETHGDFTLPMSVF
DDLYEEYTEWLKF
>HFFEDDFJ_00014 putative CtpA-like serine protease
MDDKQHTSSSDDERAEIATSNQDQQTNSSKRVHLKRWQFISILIGTILITAVITVVAYIF
INQKISGLNKTDQANLNKIENVYKILNSDYYKKQDSDKLSKAAIDGMVKELKDPYSEYLT
KEQTKSFNEGVSGDFVGIGAEMQKKNDQIMVTSPMKGSPAERAGIRPKDVITKVNGKSIK
GKALDEVVKDVRGKENTEVTLTVQRGSEEKDVKIKREKIHVKSVEYKKKDKVGVITINKF
QNDTSGELKDAVLKAHKDGLKKIVLDLRNNPGGLLDEAVKMANIFIDKGKTVVKLEKGKD
TEAIQTSNDSLKEAKDMDISILVNEGSASASEVFTGALKDYNKAKVYGSKTFGKGVVQTT
REFKDGSLLKYTEMKWLTPDGHYIHGKGIKPDVTIDTPKYQSLNVIPNTKTFKVGDDDKN
IKTIKIGLSALGYKVDNESTQFDQALENQVKAFQQTNKLEVTGEFNKETNNKFTELLVEK
ANKHDDVLDKLINILK
>HFFEDDFJ_00015 hypothetical protein
MIRLGKMSDLDQILNLVEEAKELMKEHDNEQWDDQYPLLEHFEEDIAKDYLYVLEENNKI
YGFIVVDQDQAEWYDDIDWPVNREGAFVIHRLTGSKEYKGAATELFNYVIDVVKARGAEV
ILTDTFALNKPAQGLFAKFGFHKVGEQLMEYPPYDKGEPFYAYYKNLKE
>HFFEDDFJ_00016 UDP-N-acetylglucosamine--N-acetylmuramyl-(pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase
MKKIAFTGGGTVGHVSVNLSLIPTALSQGYEALYIGSKNGIEREMIESQLPEIKYYPISS
GKLRRYISLENAKDVFKVLKGILDARKVLKKEKPDLLFSKGGFVSVPVVIAAKSLNIPTI
IHESDLTPGLANKIALKFAKKIYTTFEETLNYLPKEKADFIGATIREDLKNGNAHNGYQL
TGFNENKKVLLVMGGSLGSKKLNSIIRENLDALLQQYQVIHLTGKGLKDAQVKKSGYIQY
EFVKEELTDLLAITDTVISRAGSNAIYEFLTLRIPMLLVPLGLDQSRGDQIDNANHFADK
GYAKAIDEEQLTAQILLQELNEMEQERTRIINNMKSYEQSYTKEALFDKMIKDALN
>HFFEDDFJ_00017 hypothetical protein
MSQWKRISLLIVFTLVFGIIAFFHESRLGKWIDNEVYEFIYSSESFITTSIMLGATKVGE
VWAMLCISLLLVAYLMLKRHKIEALFFALTMALSGILNPVLKNIFDRERPTLLRLIDITG
FSFPSGHAMGSTAYFGSGIYLLKRLNQGNSKGILIGLCAAMILLISISRVYLGVHYPTDI
IAGIIGGVFCIILSTLLLRNKLIN
>HFFEDDFJ_00018 hypothetical protein
MTNPTRTKRCGGDVLCGIDNHFQLLLYISENHCQLETKTFFEYFLRIVNKTHDYAILENK
KICISH
>HFFEDDFJ_00019 Response regulator ArlR
MTQILIVEDEQNLARFLELELTHENYNVDTEYDGQDGLDKALSHYYDLIILDLMLPSING
LEICRKIRQQQSTPIIIITAKSDTYDKVAGLDYGADDYIVKPFDIEELLARIRAILRRQP
QKDIIDVNGITIDKNAFKVTVNGAEIELTKTEYDLLYLLAENKNHVMQREQILNHVWGYN
SEVETNVVDVYIRYLRNKLKPYDRDKMIETVRGVGYVIR
>HFFEDDFJ_00020 Signal transduction histidine-protein kinase ArlS
MTKRKLRNNWIIVTTMITFVTIFLFCLIIIFFLKDTLHNSELDDAERSSSDINNLFHSKT
VKDISALDLNASLGNFQEIIIYDEHNNKLFETSNDNTVRVEPGYEHRYFDRVIKKRYKGI
EYLIIKEPITTQDFKGYSLLIHSLENYDNIVKSLYIIALAFGVIATIITATISYVFSTQI
TKPLVSLSNKMIEIRRDGFQNKLQLNTNYEEIDNLANTFNEMMSQIEESFNQQRQFVEDA
SHELRTPLQIIQGHLNLIQRWGKKDPAVLEESLNISIEEMNRIIKLVEELLELTKGDVND
ISSEAQTVHINDEIRSRIHSLKQLHPDYQFDTDLTSKNLEIKMKPHQFEQLFLIFIDNAI
KYDVKNKKIKVKTRLKNKQKIIEITDHGIGIPEEDQDFIFDRFYRVDKSRSRSQGGNGLG
LSIAQKIIQLNGGSIKIKSEINKGTTFKIIF
>HFFEDDFJ_00021 2-oxoglutarate dehydrogenase E1 component
MTNERKEVSEAPVNFGANLGLMLDLYDDFLQDPSSVPEDLQVLFSTIKNDDSIVPALKST
SSQNSDGTIKRVMRLIDNIRQYGHLKADIYPVNPPKRKHVPKLEIEDFDLDQQTLEGISA
GIVSDHFADIYDNAYEAILRMEKRYKGPIAFEYTHINNNTERGWLKRRIETPYKVTLNNN
EKRALFKQLAYVEGFEKYLHKNFVGAKRFSIEGVDALVPMLQRTITIAAKEGIKNIQIGM
AHRGRLNVLTHVLEKPYEMMISEFMHTDPMKFLPEDGSLQLTAGWTGDVKYHLGGIKTTD
SYGTMQRIALANNPSHLEIVAPVVEGRTRAAQDDTQRAGAPTTDHHKAMPIIIHGDAAYP
GQGINFETMNLGNLKGYSTGGSLHIITNNRIGFTTEPIDARSTTYSTDVAKGYDVPIFHV
NADDVEATIEAIDIAMEFRKEFHKDVVIDLVGYRRFGHNEMDEPSITNPVPYQNIRKHDS
VEYVFGKKLVNEGVISEDEMHSFIEQVQKELRQAHDKINKADKMDNPDMEKPAELALPLQ
ADEQSFTFDHLKEINDALLTYPDGFNILKKLNKVLEKRHEPFNKEDGLVDWAQAEQLAFA
TILQDGTPIRLTGQDSERGTFSHRHAVLHDEQTGETYTPLHHVPDQKATFDIHNSPLSEA
AVVGFEYGYNVENKKSFNIWEAQYGDFANMSQMIFDNFLFSSRSKWGERSGLTLFLPHAY
EGQGPEHSSARLERFLQLAAENNCTVVNLSSSSNYFHLLRAQAASLDSEQMRPLVVMSPK
SLLRNKTVAKPIDEFTSGGFEPILTESYQADKVTKVILATGKMFIDLKEALAKNPDESVL
LVAIERLYPFPEEEIEALLAQLPNLEEVSWVQEEPKNQGAWLYVYPYVKVLVADKYDLSY
HGRIQRAAPAEGDGEIHKLVQNKIIENALKNN
>HFFEDDFJ_00022 Dihydrolipoyllysine-residue succinyltransferase component of 2-oxoglutarate dehydrogenase complex
MPEVKVPELAESITEGTIAEWLKNVGDSVEKGEAILELETDKVNVEVVSEEAGVLSEQLA
SEGDTVEVGQAIAIIGEGSGNASKENSNDNTPQQNEETNNKKEETTNNSVDKAEVNQAND
DNQQRINATPSARRYARENGVNLAEVSPKTNDVVRKEDIDKKQQAPASTQTTQQAPAKEE
KKYNQYPTKPVIREKMSRRKKTAAKKLLEVSNNTAMLTTFNEVDMTNVMELRKRKKEQFM
KDHDGTKLGFMSFFTKASVAALKKYPEVNAEIDGDDMITKQYYDIGVAVSTDDGLLVPFV
RDCDKKNFAEIEAEIANLAVKAREKKLGLDDMVNGSFTITNGGIFGSMMSTPIINGNQAA
ILGMHSIITRPIAIDQDTIENRPMMYIALSYDHRIIDGKEAVGFLKTIKELIENPEDLLL
ES
